4.4 Article

btn1 Affects endocytosis, polarization of sterol-rich membrane domains and polarized growth in Schizosaccharomyces pombe

期刊

TRAFFIC
卷 9, 期 6, 页码 936-950

出版社

WILEY
DOI: 10.1111/j.1600-0854.2008.00735.x

关键词

batten; btn1; CLN3; end4; endocytosis; F-actin; myo1; neuronal ceroid lipofuscinosis; polarity; sla2; sterol; Sz. pombe

资金

  1. Medical Research Council Funding Source: Medline
  2. Wellcome Trust Funding Source: Medline

向作者/读者索取更多资源

btn1, the Schizosaccharomyces pombe orthologue of the human Batten disease gene CLN3, exerts multiple cellular effects. As well as a role in vacuole pH homoeostasis, we now show that Btn1p is essential for growth at high temperatures. Its absence results in progressive defects at 37 degrees C that culminate in total depolarized growth and cell lysis. These defects are preceded by a progressive failure to correctly polarize sterol-rich domains after cytokinesis and are accompanied by loss of Myo1p localization. Furthermore, we found that in Sz. pombe, sterol spreading is linked to defective formation/polarization of F-actin patches and disruption of endocytosis and that these processes are aberrant in btn1 Delta cells. Consistent with a role for Btn1p in polarized growth, Btn1p has an altered location at 37 degrees C and is retained in actin-dependent endomembrane structures near the cell poles or septum.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Kufs disease due to mutation of CLN6: clinical, pathological and molecular genetic features

Samuel F. Berkovic, Karen L. Oliver, Laura Canafoglia, Penina Krieger, John A. Damiano, Michael S. Hildebrand, Michela Morbin, Danya F. Vears, Vito Sofia, Loretta Giuliano, Barbara Garavaglia, Alessandro Simonati, Filippo M. Santorelli, Antonio Gambardella, Angelo Labate, Vincenzo Belcastro, Barbara Castellotti, Cigdem Ozkara, Adam Zeman, Julia Rankin, Sara E. Mole, Umberto Aguglia, Michael Farrell, Sulekha Rajagopalan, Alan McDougall, Susan Brammah, Frederick Andermann, Eva Andermann, Hans-Henrik M. Dahl, Silvana Franceschetti, Stirling Carpenter

Review Clinical Neurology

Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis

Sara E. Mole, Glenn Anderson, Heather A. Band, Samuel F. Berkovic, Jonathan D. Cooper, Sophia-Martha Kleine Holthaus, Tristan R. Mckay, Diego L. Medina, Ahad A. Rahim, Angela Schulz, Alexander J. Smith

LANCET NEUROLOGY (2019)

Review Biochemistry & Molecular Biology

Moving towards a new era of genomics in the neuronal ceroid lipofuscinoses

Elisabeth S. Butz, Uma Chandrachud, Sara E. Mole, Susan L. Cotman

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)

Review Biochemistry & Molecular Biology

Future perspectives: What lies ahead for Neuronal Ceroid Lipofuscinosis research?

Jonathan D. Cooper, Sara E. Mole

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)

Review Biochemistry & Molecular Biology

Experimental gene therapies for the NCLs

Wenfei Liu, Sophia-Martha Kleine-Holthaus, Saul Herranz-Martin, Mikel Aristorena, Sara E. Mole, Alexander J. Smith, Robin R. Ali, Ahad A. Rahim

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)

Editorial Material Biochemistry & Molecular Biology

Special edition: The NCLs/Batten disease Preface

Ahad A. Rahim, Claire Russell, Sara E. Mole

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)

Article Biotechnology & Applied Microbiology

Gene Therapy Targeting the Inner Retina Rescues the Retinal Phenotype in a Mouse Model of CLN3 Batten Disease

Sophia-Martha Kleine Holthaus, Mikel Aristorena, Ryea Maswood, Olha Semenyuk, Justin Hoke, Aura Hare, Alexander J. Smith, Sara E. Mole, Robin R. Ali

HUMAN GENE THERAPY (2020)

Article Pediatrics

Revealing the clinical phenotype of atypical neuronal ceroid lipofuscinosis type 2 disease: Insights from the largest cohort in the world

Charles M. Lourenco, Andre Pessoa, Carmen C. Mendes, Carolina Rivera-Nieto, Diane Vergara, Monica Troncoso, Emily Gardner, Francisca Mallorens, Lina Tavera, Luis A. Lizcano, Nora Atanacio, Norberto Guelbert, Norma Specola, Nury Mancilla, Carolina F. M. de Souza, Sara E. Mole

Summary: Neuronal ceroid lipofuscinosis type 2 (CLN2) is a neurodegenerative lysosomal storage disorder primarily affecting children aged 2-4 years, with seizures, language abnormalities, and behavioral disorders being the first manifestations in atypical cases observed in Latin American patients at an older age of 6 years. Early diagnosis of CLN2 in children presenting with such symptoms is crucial for timely initiation of specific therapy.

JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2021)

Article Multidisciplinary Sciences

Urine proteomics analysis of patients with neuronal ceroid lipofuscinoses

Katharina Iwan, Robert Clayton, Philippa Mills, Barbara Csanyi, Paul Gissen, Sara E. Mole, David N. Palmer, Kevin Mills, Wendy E. Heywood

Summary: NCL is a group of rare neurodegenerative disorders characterized by accumulation of cellular storage bodies. Current therapeutic options are limited, but urine biomarkers may help monitor disease progression and treatment response. Through proteomic analysis and a targeted assay, certain proteins were found to be increased in NCL patients, which could be used to monitor the effectiveness of future therapies.

ISCIENCE (2021)

Article Genetics & Heredity

Guidelines on the diagnosis, clinical assessments, treatment and management for CLN2 disease patients

Sara E. Mole, Angela Schulz, Eben Badoe, Samuel F. Berkovic, Emily C. de Los Reyes, Simon Dulz, Paul Gissen, Norberto Guelbert, Charles M. Lourenco, Heather L. Mason, Jonathan W. Mink, Noreen Murphy, Miriam Nickel, Joffre E. Olaya, Maurizio Scarpa, Ingrid E. Scheffer, Alessandro Simonati, Nicola Specchio, Ina Von Loebbecke, Raymond Y. Wang, Ruth E. Williams

Summary: These guidelines provide robust evidence-based, expert-agreed recommendations on the risks/benefits of disease-modifying treatments and the medical interventions used to manage CLN2 disease. The program addresses the clinical need to complement other available information.

ORPHANET JOURNAL OF RARE DISEASES (2021)

Article Medicine, Research & Experimental

Repurposing of tamoxifen ameliorates CLN3 and CLN7 disease phenotype

Chiara Soldati, Irene Lopez-Fabuel, Luca G. Wanderlingh, Marina Garcia-Macia, Jlenia Monfregola, Alessandra Esposito, Gennaro Napolitano, Marta Guevara-Ferrer, Anna Scotto Rosato, Einar K. Krogsaeter, Dominik Paquet, Christian M. Grimm, Sandro Montefusco, Thomas Braulke, Stephan Storch, Sara E. Mole, Maria A. De Matteis, Andrea Ballabio, Julio L. Sampaio, Tristan McKay, Ludger Johannes, Juan P. Bolanos, Diego L. Medina

Summary: The research found potential therapeutic effects of tamoxifen for certain types of Batten diseases, such as CLN3 and CLN7. Tamoxifen can reduce the accumulation of Gb3 in certain BD cells by activating the transcription factor EB. In a mouse model, tamoxifen reduced the accumulation of Gb3 and SCMAS, improved neuroinflammation, and enhanced motor coordination.

EMBO MOLECULAR MEDICINE (2021)

Correction Multidisciplinary Sciences

Global network analysis in Schizosaccharomyces pombe reveals three distinct consequences of the common 1-kb deletion causing juvenile CLN3 disease (vol 11, 6332, 2021)

Christopher J. Minnis, StJohn Townsend, Julia Petschnigg, Elisa Tinelli, Juerg Baehler, Claire Russell, Sara E. Mole

SCIENTIFIC REPORTS (2021)

Article Medicine, Research & Experimental

Safe and stable generation of induced pluripotent stem cells using doggybone DNA vectors

Christopher D. Thornton, Stuart Fielding, Kinga Karbowniczek, Alicia Roig-Merino, Alysha E. Burrows, Lorna M. FitzPatrick, Aseel Sharaireh, John P. Tite, Sara E. Mole, Richard P. Harbottle, Lisa J. Caproni, Tristan R. Mckay

Summary: The study reports the first-ever application of doggybone DNA (dbDNA) vectors to generate human iPSCs, which showed greater stability and safety potential compared to bacterially derived vectors in cellular activities.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)

Review Biochemistry & Molecular Biology

Sex bias and omission exists in Batten disease research: Systematic review of the use of animal disease models

Annie McShane, Sara E. Mole

Summary: Batten disease is a neurodegenerative disorder that mainly affects children, and there is a lack of consideration for sex differences in research using animal models. However, in recent years, there has been an increasing recognition of the importance of considering sex as a biological variable, and recommendations have been made to address this issue.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2022)

Article Biochemistry & Molecular Biology

The Batten disease protein CLN3 is important for stress granules dynamics and translational activity

Emily L. Relton, Nicolas J. Roth, Seda Yasa, Abuzar Kaleem, Guido Hermey, Christopher J. Minnis, Sara E. Mole, Tatyana Shelkovnikova, Stephane Lefrancois, Peter J. McCormick, Nicolas Locker

Summary: The assembly of membrane-less organelles called stress granules (SGs) is important for cells to respond and adapt to stress. SGs condense stalled mRNAs and proteins to modulate cellular activities and promote survival. Disassembly of SGs is crucial for cell viability, and mutations leading to persistent or aberrant SGs are associated with neurodegenerative diseases. In the case of CLN3 mutations, which cause juvenile neuronal ceroid lipofuscinosis, loss of CLN3 function disrupts SG dynamics and poses challenges for treating this childhood disease.

JOURNAL OF BIOLOGICAL CHEMISTRY (2023)

暂无数据